• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Global Aspiration & Biopsy Needles Market to See Strong Growth

Global Aspiration & Biopsy Needles Market to See Strong Growth

by Glenn S. Demby | Apr 1, 2022 | Articles, Essential, Industry Buzz-lir, Laboratory Industry Report

According to a recent report, this market will see almost seven percent annual growth over the next five years, reaching US $1.29 billion in 2026.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
NCI Program Expands Access to Key Diagnostic for Childhood Cancers

NCI Program Expands Access to Key Diagnostic for Childhood Cancers

by Rachel Muenz | Mar 28, 2022 | Articles, News, Open Content

A new initiative launched by the National Institutes of Health’s National Cancer Institute (NCI) on March 21 will bring a state-of-the art diagnostic option to children, adolescents, and young adults who have recently been diagnosed with central nervous system tumors....
Certain Gut Microbes May Identify Pancreatic Cancer Sooner

Certain Gut Microbes May Identify Pancreatic Cancer Sooner

by BMJ | Mar 10, 2022 | Articles, News, Open Content

A specific panel of gut microbes may identify pancreatic cancer, irrespective of how far the disease has progressed, suggests research published online in the journal Gut. The findings offer hope of a new non-invasive method of diagnosing this hard to treat disease,...
New Microchip Could Lead To Home-Based Prostate Cancer Tests

New Microchip Could Lead To Home-Based Prostate Cancer Tests

by Toyohashi University of Technology | Mar 7, 2022 | Articles, News, Open Content

Associate professor Kazuhiro Takahashi and Tomoya Maeda (a second-year master’s student) and other members of the Department of Electrical and Electronic Information Engineering at Toyohashi University of Technology have developed a semiconductor sensor capable...
US FDA Approves FoundationOne®CDx as a Companion Diagnostic for KEYTRUDA®

US FDA Approves FoundationOne®CDx as a Companion Diagnostic for KEYTRUDA®

by Foundation Medicine | Feb 28, 2022 | Articles, News, Open Content

CAMBRIDGE, MA — Foundation Medicine, Inc. announced on Feb. 21 that it received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne CDx to be used as a companion diagnostic to identify patients with Microsatellite Instability High (MSI-H)...
« Older Entries
Next Entries »

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com